Mint Tower Capital Management’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-1,260
Closed -$75K 363
2021
Q3
$75K Buy
+1,260
New +$83K 0.01% 295

Other funds holding BMY

Mint Tower Capital Management's BMY Position: Q4 2021 in Review

Mint Tower Capital Management sold out of Bristol-Myers Squibb (BMY) in Q4 2021, closing a stake of 1,260 shares — an estimated $75K sold.

Mint Tower Capital Management first reported a position in BMY in Q3 2021 and held it in 1 quarter. The position peaked at $75K in Q3 2021. 2,444 funds tracked by Wall St. Rank hold BMY as of Q4 2021.

  • Mint Tower Capital Management reported no remaining Bristol-Myers Squibb position as of Q4 2021 after selling out during the quarter.
  • Mint Tower Capital Management sold 1,260 Bristol-Myers Squibb shares in Q4 2021, an estimated $75K.
  • Mint Tower Capital Management first reported a position in Bristol-Myers Squibb in Q3 2021 and held it in 1 quarter.
  • Mint Tower Capital Management's Bristol-Myers Squibb position peaked at $75K in Q3 2021.
  • 2,444 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2021.

Based on Mint Tower Capital Management's 13F filing for Q4 2021, filed 4 Feb 2022.